Drug intelligence / Profile preview

4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine

Development stage: Unknown
Modality: Small Molecules

Overview

4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine is a small molecule organic compound classified as an aminopyrimidine derivative. It features a pyrimidine ring substituted with an amino group at position 2, a methyl group at position 6, and a (2-methoxy)ethoxyl group at position 4. The compound is of interest in pharmaceutical research but does not have any widely recognized therapeutic indication or mechanism of action described in available sources[1][3][4].

Other names: 4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine

Targets

HSP90AA1 (Heat shock protein HSP90-alpha)

Beyond the preview

Go deeper on 4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine.

Explore the full profile